MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial

BACKGROUND: This study aimed at assessing the long-term effects of intranasal insulin (INI) on cognition and gait in older people with and without type 2 diabetes mellitus (T2DM). METHODS: Phase 2 randomized, double-blinded trial consisted of 24 week treatment with 40 IU of INI (Novolin(®) R, off-la...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Vera, Mantzoros, Christos S., Novak, Peter, McGlinchey, Regina, Dai, Weiying, Lioutas, Vasileios, Buss, Stephanie, Fortier, Catherine B., Khan, Faizan, Aponte Becerra, Laura, Ngo, Long H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046533/
https://www.ncbi.nlm.nih.gov/pubmed/35482079
http://dx.doi.org/10.1007/s00415-022-11119-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046533/
https://www.ncbi.nlm.nih.gov/pubmed/35482079
http://dx.doi.org/10.1007/s00415-022-11119-6

Ejemplares similares